Clinical Trial Update: Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing acupuncture for treating adverse events related to intravesical BCG in high-risk non-muscle invasive bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Bladder Urothelial Carcinoma
• Bladder Urothelial Carcinoma in Situ
• Stage 0a Bladder Cancer
• Stage 0is Bladder Cancer
• Superficial Bladder Urothelial Carcinoma

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Bladder Urothelial Carcinoma In Situ, Recurrent Bladder Urothelial Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-01-02